rs34398108

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The variant allele was found at a frequency of 0.477 in 151,568 control chromosomes in the GnomAD database, including 21,698 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 21698 hom., cov: 34)

Consequence

IGH
intragenic

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.114

Publications

4 publications found
Variant links:
Genes affected

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.672 is higher than 0.05.

Variant Effect in Transcripts

 

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Frequencies

GnomAD3 genomes
AF:
0.478
AC:
72347
AN:
151450
Hom.:
21701
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.732
Gnomad AMR
AF:
0.391
Gnomad ASJ
AF:
0.694
Gnomad EAS
AF:
0.493
Gnomad SAS
AF:
0.507
Gnomad FIN
AF:
0.594
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.677
Gnomad OTH
AF:
0.518
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.477
AC:
72328
AN:
151568
Hom.:
21698
Cov.:
34
AF XY:
0.470
AC XY:
34778
AN XY:
74038
show subpopulations
African (AFR)
AF:
0.121
AC:
4997
AN:
41414
American (AMR)
AF:
0.391
AC:
5937
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.694
AC:
2400
AN:
3460
East Asian (EAS)
AF:
0.492
AC:
2521
AN:
5128
South Asian (SAS)
AF:
0.507
AC:
2420
AN:
4772
European-Finnish (FIN)
AF:
0.594
AC:
6261
AN:
10548
Middle Eastern (MID)
AF:
0.605
AC:
173
AN:
286
European-Non Finnish (NFE)
AF:
0.677
AC:
45860
AN:
67764
Other (OTH)
AF:
0.523
AC:
1096
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1304
2608
3913
5217
6521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.573
Hom.:
3529
Bravo
AF:
0.445
Asia WGS
AF:
0.491
AC:
1709
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
10
DANN
Benign
0.62
PhyloP100
-0.11

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs34398108;
hg19: chr14-106169056;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.